Kelix bio has announced two deals to expand its presence in Africa. The company is set to acquire 14 oncology injectable products from Germany-based Vitane. Furthermore, Kelix has acquired Pharmaceutical Institute, a pharmaceutical company established in Rabat, to enter Morocco. The pan-African company has also invested in Malta.
The pan-African specialty generics company, Kelix bio, has announced a deal with Germany-based Vitane to acquire 14 oncology injectable products to gain “faster market access, particularly, into more tightly regulated jurisdictions.”
Hocine Sidi-Said, CEO of Kelix said, “The Vitane portfolio is a range of high-quality products that are highly relevant to...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
